249 related articles for article (PubMed ID: 14688314)
21. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms.
Finnegan A; Grusby MJ; Kaplan CD; O'Neill SK; Eibel H; Koreny T; Czipri M; Mikecz K; Zhang J
J Immunol; 2002 Sep; 169(6):3345-52. PubMed ID: 12218156
[TBL] [Abstract][Full Text] [Related]
22. Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis.
Karachunski PI; Ostlie NS; Okita DK; Garman R; Conti-Fine BM
J Neuroimmunol; 1999 Jan; 93(1-2):108-21. PubMed ID: 10378874
[TBL] [Abstract][Full Text] [Related]
23. The homeostasis but not the differentiation of T cells is regulated by p27(Kip1).
Shen R; Kaplan MH
J Immunol; 2002 Jul; 169(2):714-21. PubMed ID: 12097373
[TBL] [Abstract][Full Text] [Related]
24. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC
J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850
[TBL] [Abstract][Full Text] [Related]
25. Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism.
Land KJ; Gudapati P; Kaplan MH; Seetharamaiah GS
Endocrinology; 2006 Jan; 147(1):111-9. PubMed ID: 16195404
[TBL] [Abstract][Full Text] [Related]
26. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
27. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
[TBL] [Abstract][Full Text] [Related]
28. Neonatal tolerance in the absence of Stat4- and Stat6- dependent Th cell differentiation.
Chang HC; Zhang S; Kaplan MH
J Immunol; 2002 Oct; 169(8):4124-8. PubMed ID: 12370340
[TBL] [Abstract][Full Text] [Related]
29. T cells and cytokines in the pathogenesis of acquired myasthenia gravis.
Milani M; Ostlie N; Wang W; Conti-Fine BM
Ann N Y Acad Sci; 2003 Sep; 998():284-307. PubMed ID: 14592887
[TBL] [Abstract][Full Text] [Related]
30. IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice.
Huda R; Strait RT; Tüzün E; Finkelman FD; Christadoss P
J Neuroimmunol; 2015 Apr; 281():68-72. PubMed ID: 25867470
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet.
Lin JT; Martin SL; Xia L; Gorham JD
J Immunol; 2005 May; 174(10):5950-8. PubMed ID: 15879087
[TBL] [Abstract][Full Text] [Related]
32. Effect of targeted disruption of signal transducer and activator of transcription (Stat)4 and Stat6 genes on the autoimmune diabetes development induced by multiple low doses of streptozotocin.
Cetkovic-Cvrlje M; Uckun FM
Clin Immunol; 2005 Mar; 114(3):299-306. PubMed ID: 15721841
[TBL] [Abstract][Full Text] [Related]
33. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
[TBL] [Abstract][Full Text] [Related]
34. Stat4 is critical for the balance between Th17 cells and regulatory T cells in colitis.
Xu J; Yang Y; Qiu G; Lal G; Yin N; Wu Z; Bromberg JS; Ding Y
J Immunol; 2011 Jun; 186(11):6597-606. PubMed ID: 21525389
[TBL] [Abstract][Full Text] [Related]
35. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.
Chung DR; Kasper DL; Panzo RJ; Chitnis T; Grusby MJ; Sayegh MH; Tzianabos AO
J Immunol; 2003 Feb; 170(4):1958-63. PubMed ID: 12574364
[TBL] [Abstract][Full Text] [Related]
36. Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma.
Ostrand-Rosenberg S; Grusby MJ; Clements VK
J Immunol; 2000 Dec; 165(11):6015-9. PubMed ID: 11086031
[TBL] [Abstract][Full Text] [Related]
37. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
[TBL] [Abstract][Full Text] [Related]
38. Stat5a inhibits IL-12-induced Th1 cell differentiation through the induction of suppressor of cytokine signaling 3 expression.
Takatori H; Nakajima H; Kagami S; Hirose K; Suto A; Suzuki K; Kubo M; Yoshimura A; Saito Y; Iwamoto I
J Immunol; 2005 Apr; 174(7):4105-12. PubMed ID: 15778369
[TBL] [Abstract][Full Text] [Related]
39. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.
Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG
J Immunol; 1999 Nov; 163(10):5374-82. PubMed ID: 10553062
[TBL] [Abstract][Full Text] [Related]
40. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion.
Zhu J; Guo L; Watson CJ; Hu-Li J; Paul WE
J Immunol; 2001 Jun; 166(12):7276-81. PubMed ID: 11390477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]